PADA-V2 Addendum Photoperiod–Adenosine–Desensitization–Aging: Mechanistic Completion, Tier Re-classification, and Supplementary Experimental Design

Background. The PADA hypothesis proposes that adenosine-mediated subjective sleep pressure and acute cellular stress are not determined by the absolute extracellular adenosine concentration alone, but jointly by ligand concentration and the G-protein coupling state of adenosine receptors, the latter quantified as a GRK-mediated homologous desensitization level D. The parent manuscript (PADA-V2, 2026-08) established the photoperiod–SCN–melatonin–adenosine (P-S-M-A) axis, the variable D, a four-tier inference scheme, and a three-stage experimental programme. It nevertheless left four structural gaps: downstream cascades were described only phenomenologically; D was treated as a single variable without distinguishing reversible from quasi-irreversible desensitization; brain-region receptor heterogeneity was omitted; and hypothalamic sleep-executive circuitry was not integrated. In addition, the parent manuscript contains several statement-level errors and one directional contradiction. Objective. This document performs two functions. First, it completes the mechanistic treatment of the four gaps. Second, it formally supersedes nine identified defects of the parent manuscript through a parallel-addendum-plus-clause-supersession mechanism, without re-releasing the parent version. Principal extensions. (1) GPCR desensitization is separated into D₁ (membrane-retained, rapidly reversible) and D₂ (endocytic–lysosomal, slowly reversible), and D is redefined as a two-axis variable comprising a benefit axis (attenuation of acute G-protein output) and a cost axis (residual β-arrestin signalling plus depletion of the functional surface receptor pool). This replaces the earlier one-dimensional higher-is-better-or-worse formulation. (2) The A₂A cascade is dissected with explicit acknowledgement that A₂A modulation of NF-κB is strongly cell-type- and time-dependent—predominantly anti-inflammatory in peripheral immune cells, and pro-inflammatory in microglia only after sustained receptor up-regulation. The previously proposed “aging amplifier” is therefore demoted to a conditional second-tier inference and renamed a conditional aging-signal modulation axis. (3) Brain-region asynchronous desensitization is proposed as one non-exclusive candidate explanation for the dissociated phenotype of somatic fatigue with cerebral hyper-arousal. (4) The VLPO–TMN circuit is integrated, and Process-S output is restated as a qualitative multivariate function of adenosine, D₁ and D₂, with the classical single-variable formulation recovered as the D→0 limit. Methodological additions. At the in vitro level: D₁/D₂ discrimination by three convergent evidence chains, functional downstream readouts, a side-path/main-path ratio R, SASP and mTOR-axis markers (with mandatory parallel assessment of p-AMPK and p-TSC2 to resolve direction), and a continuous-versus-pulsatile contrast built on a pre-registered dose–time matrix (peak, frequency, duty cycle, AUC, and five recovery sampling points). At the in vivo level: region-resolved sampling by laser microdissection or fibre photometry with mandatory normalization, and A₂A-KO, A₁-KO, GRK2/3 central conditional knockout and β-arrestin2-KO as a core falsification arm with four separately adjudicable outcomes. Human work remains restricted to observational cohorts, with peripheral surrogates explicitly graded and limited to correlational inference. Self-limitation. No original data are presented. No component of the proposed cascade has been measured simultaneously in the living human brain. The pro-inflammatory direction of A₂A holds only under defined cellular conditions; the direction of cAMP–PKA action on mTORC1 is not settled in the field; the direction of photoperiodic modulation of the adenosine system is likewise undetermined. All three are flagged as direction-pending and are not used as conclusions. The framework also does not address the immune and metabolic functions of sleep—an independent and plausibly more important dimension—and this is declared as a structural blind spot rather than defended. This revision adds six previously unlisted limitations that argue against the hypothesis, and withdraws the right-hand limb of the sleep-duration U-curve outright. Nature of this document. This is a falsifiable-hypothesis archive without original experimental or clinical data. It does not constitute medical, therapeutic, sleep-timing or light-exposure advice. This addendum should be cited together with the parent manuscript PADA-V2.